Published : Oct-2017
No. of Pages : 45
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Epilepsy: Executive Summary 4
2.1 Related Reports 7
2.2 Upcoming Related Reports 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 8
3.3 Global and Historical Trends 9
3.3.1 US 11
3.3.2 5EU 12
3.3.3 Japan 12
3.4 Forecast Methodology 13
3.4.1 Sources 14
3.4.2 Forecast Assumptions and Methods 18
3.5 Epidemiological Forecast for Epilepsy (2016-2026) 28
3.5.1 Lifetime Diagnosed Prevalent Cases of Epilepsy 28
3.5.2 Active Diagnosed Prevalent Cases of Epilepsy 29
3.5.3 Age-Specific Active Diagnosed Prevalent Cases of Epilepsy 30
3.5.4 Sex-Specific Active Diagnosed Prevalent Cases of Epilepsy 31
3.5.5 Active Diagnosed Prevalent Cases by Seizure Type 32
3.5.6 Drug Resistant Active Diagnosed Prevalent Cases 33
3.6 Discussion 34
3.6.1 Epidemiological Forecast Insight 34
3.6.2 Limitations of the Analysis 36
3.6.3 Strengths of the Analysis 36
4 Appendix 37
4.1 Bibliography 37
4.2 Primary Research - Prescriber Survey 42
4.3 About the Authors 42
4.3.1 Epidemiologist 42
4.3.2 Reviewers 42
4.3.3 Global Director of Therapy Analysis and Epidemiology 43
4.3.4 Global Head and EVP of Healthcare Operations and Strategy 44
4.4 About GlobalData 45
4.5 Contact Us 45
4.6 Disclaimer 45
1.1 List of Tables
Table 1: Risk Factors and Comorbidities for Epilepsy 9
Table 2: 7MM, Lifetime Diagnosed Prevalent Cases of Epilepsy, Men and Women, All Ages, Select Years 2016-2026. 29
Table 3: 7MM, Active Diagnosed Prevalent Cases of Epilepsy, Men and Women, All Ages, Select Years 2016-2026 30
Table 4: High-Prescribing Physicians (non-KOLs) Surveyed, By Country 42
1.2 List of Figures
Figure 1: 7MM, Lifetime Diagnosed Prevalent Cases of Epilepsy, Both Sexes, All Ages, 2016 and 2026 5
Figure 2: 7MM, Active Diagnosed Prevalent Cases of Epilepsy, Both Sexes, All Ages, 2016 and 2026 6
Figure 3: 7MM Age-Standardized Lifetime Diagnosed Prevalence, Men, Women, All Ages, 2016 (%) 10
Figure 4: 7MM Age-standardized Active Diagnosed Prevalence, Men, Women, All Ages, 2016 (%) 11
Figure 5: The Sources Used to Calculate the Lifetime Diagnosed Prevalence of Epilepsy 14
Figure 6: The Sources Used and Not Used in the Forecast for the Active Diagnosed Prevalence 15
Figure 7: The Sources Used and Not Used in the Forecast for the Seizure Type Distribution of Active Diagnosed Prevalent Cases 17
Figure 8: The Sources Used in the Forecast for the Drug Resistant Active Diagnosed Prevalent Cases 18
Figure 9: 7MM, Age-Specific Active Diagnosed Prevalent Cases of Epilepsy, Men and Women, All Ages, 2016 31
Figure 10: 7MM Sex-Specific Active Diagnosed Prevalent Cases of Epilepsy, All Ages, 2016. 32
Figure 11: 7MM, Active Diagnosed Prevalent Cases of Epilepsy by Seizure Type, Men and Women, All Ages, 2016 33
Figure 12: 7MM, Active Diagnosed Prevalent Cases by Response to AED Treatment, Men and Women, All Ages, 2016. 34
